LDOS vs NTLA · P/E 16, rev $8.96B vs rev $22.7M
Leidos Holdings Inc (LDOS) versus Intellia Therapeutics Inc (NTLA) — a side-by-side from cached financials, not a winner call.
Leidos Holdings Inc (LDOS) is a information technology services company listed on US.
Intellia Therapeutics Inc (NTLA) is a biotechnology company listed on US.
Latest reported LDOS revenue for 2026-07-03 was $8.96B. Net income was $682.0M. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
Latest reported NTLA revenue for 2026-06-30 was $22.7M. Net income was -$202.9M. Revenue was up 50.9% from 2026-03-31 to 2026-06-30. NTLA currently screens at market cap $1.19B.
LDOS currently screens at market cap $20.04B and trailing P/E 15.7. NTLA currently screens at market cap $1.19B.
Not investment advice. Open the LDOS and NTLA stock pages for the full models.
Not investment advice.